Efficacy and safety of anti-PD-1-based therapies in advanced melanoma across acral and mucosal subtypes: a nationwide retrospective cohort study
Yuan Qiao, Xiao Fu, Iltaf Hussain, Weihong Ge, Wei Yang, Renbin Jiang, Xiaoyan Dai, Haisheng Chen, Jinyi Zhao, Meng Tang, Fei Mu, Hao Wang, Qiuhui Wu, Xing Xia, Yunnan Zhang, Suzhi Ji, Ying Xu, Xinrui Cao, Jiexin Wang, Le Gao, Jingwen Wang, Yu Yao, Yu Fang · 2026
Read Efficacy and safety of anti-PD-1-based therapies in advanced melanoma across acral and mucosal subtypes: a nationwide retrospective cohort study by Yuan Qiao, Xiao Fu, Iltaf Hussain, Weihong Ge, Wei Yang, Renbin Jiang, Xiaoyan Dai, Haisheng Chen, Jinyi Zhao, Meng Tang, Fei Mu, Hao Wang, Qiuhui Wu, Xing Xia, Yunnan Zhang, Suzhi Ji, Ying Xu, Xinrui Cao, Jiexin Wang, Le Gao, Jingwen Wang, Yu Yao, Yu Fang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13578169.txt.
Description
Yuan Qiao and colleagues report a nationwide look back at care for advanced melanoma in China, published in 2026. Their group followed 431 patients treated with drugs that block the PD-1 protein between mid-2018 and mid-2023. Acral tumors, which grow on palms and soles, made up the largest share, followed by mucosal and skin forms.
Inside, the authors compare single-drug treatment with several paired and triple drug mixes, tracking how long the disease stayed quiet and how long patients lived. Two mixes tied to blocking blood vessel growth showed a clear gain for acral and mucosal cases. One triple mix raised the risk of severe side effects without helping survival, so the authors urge care with that option.
Catalog record
| CREATOR | Yuan Qiao, Xiao Fu, Iltaf Hussain, Weihong Ge, Wei Yang, Renbin Jiang, Xiaoyan Dai, Haisheng Chen, Jinyi Zhao, Meng Tang, Fei Mu, Hao Wang, Qiuhui Wu, Xing Xia, Yunnan Zhang, Suzhi Ji, Ying Xu, Xinrui Cao, Jiexin Wang, Le Gao, Jingwen Wang, Yu Yao, Yu Fang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40625 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |